Back to MW MARSHALL WACE, LLP
LYEL5 quarters
Position history for MWMARSHALL WACE, LLP's holdings in LYELL IMMUNOPHARMA INC
MARSHALL WACE, LLP holds 106,300 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $1.5M as of 2026-Q2. The position was decreased (-28.4% shares). LYEL represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$1.5M
Current Shares
106,300
Total Value Change
+$1.4M
Total Shares Change
+95,720
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.